FIELD: medicine.
SUBSTANCE: invention can be used to treat female infertility in non-diabetic mammals by administering a therapeutically effective amount of a tungsten (VI) salt with a pharmaceutically or veterinarily suitable cationic group or a solvate thereof.
EFFECT: method allows to restore ovulation and increase zygote implantation into the uterine wall.
25 cl, 4 tbl
Authors
Dates
2017-11-13—Published
2014-01-21—Filed